Vermont Senate Panel Previews Amendment Narrowing House-Passed Safe Drug Consumption Site Bill To Single Facility
Justice Department Is Investigating Marijuana-Related Businesses Over COVID Relief Loans, Industry Sources Say
New Hampshire Governor Indicates He Won’t Sign House-Passed Marijuana Legalization Bill Unless Senate Makes Changes
Amended Nebraska Bill Reduces Proposed Hemp And CBD Tax Rate From 100% Down To 25%
These Marijuana Companies Are Funding Florida’s Legalization Ballot Campaign, New Records Show
Medical Marijuana Patient Enrollment Grew 610% Since 2016, Showing ‘Increasing Cultural Acceptance Of Cannabis,’ Federal Study Finds
Use Of Psilocybin For Mental Health Treatment ‘Not Associated’ With Risk Of Paranoia, American Medical Association Study Finds
More Than 90% Of Smokable Hemp Samples Analyzed By Researchers Contained Illegal Amounts Of THC, New Federal Study Finds
CBD’s Potential To Treat Pain, Cancer, Schizophrenia, COVID And Other Conditions Highlighted In New Scientific Review
Teen Marijuana Use Has Declined In Washington Since Legalization, New State Research Shows
Former Minnesota Gov. Jesse Ventura Promotes New Cannabis Brand Ahead Of 4/20 That He’d ‘Offer To You’ On Governor’s Mansion Visit
Colorado Amendment Addresses Concerns On Banning Social Media Marijuana Posts, But Questions On Psychedelics And Other Drugs Remain
Former Minnesota Governor Jesse Ventura Launches His Own Cannabis Brand, Fulfilling A ‘Lifelong Dream’
Marijuana Rolling Paper Company Seeks Content Creator To ‘Get Paid To Smoke Weed’ For $70,420 Salary
Nevada’s First Marijuana Consumption Lounge Officially Opens, With Top Lawmaker Hitting A Joint At 4:20
The Legal Marijuana Industry Now Supports More Than 440,000 Full-Time Jobs, Up 5% From Last Year, Report Finds
Missouri Warns Marijuana License Applicants Of ‘Predatory Practices’ Around Social Equity Status
Missouri Marijuana Worker Union Dispute Could Have Major Implications For National Labor Law
New Mexico Retailers Set A New Marijuana Sales Record In March
Missouri Revokes Nine Marijuana Business Licenses Over Social Equity Ineligibility
Vermont Senate Panel Previews Amendment Narrowing House-Passed Safe Drug Consumption Site Bill To Single Facility
New Hampshire House Passes Bill To Legalize Marijuana Through ‘Agency Store’ Model That Senators Oppose
FDA Head Says There’s ‘No Reason For DEA To Delay’ Rescheduling Marijuana
Ohio Governor Pushes Lawmakers To Ban Public Marijuana Consumption And Delta-8 THC Products In State Of The State Speech
Pennsylvania Lawmakers Talk Marijuana Justice And Equity Issues At Hearing Following New Legalization Bill’s Introduction
FDA head tells DEA to not delay cannabis rescheduling (Newsletter: April 12, 2024)
Ohio cannabis sales could launch early (Newsletter: April 11, 2024)
Schumer cannabis legalization bill coming soon (Newsletter: April 10, 2024)
Feds seize state-licensed cannabis (Newsletter: April 9, 2024)
DOJ says legal cannabis boosts tourism (Newsletter: April 8, 2024)
Published
on
By
Maryland lawmakers are considering a new proposal to create a task force to study and make specific recommendations about the best path forward to legalize and regulate certain psychedelics.
The bill from Del. Pam Guzzone (D) and five cosponsors would establish a “Task Force on Responsible Use of Natural Psychedelic Substances” under the state Department of Health.
While several states have advanced similar legislation on exploring psychedelics legalization, the Maryland legislation stands out in its level of detail for what members will be required to study and make policy recommendations on, including “systems to support statewide online sales of natural psychedelic substances with home delivery,” for example.
The task force would need to consist of four members of the legislature appointed by leadership, secretaries or designees of five state agencies, a representative of the Maryland Cannabis Administration (MCA) and 15 governor-appointed positions, including people with backgrounds in public health, drug policy reform advocacy and law enforcement.
They would need to study existing laws related to psychedelics, opportunities to “maximize public benefits of responsible access to and use of natural psychedelic substances,” risks and methods of mitigating risk, barriers to access within the health care system and more.
By December 15, 2025, the panel would need to submit a report to the governor and legislature with findings and recommendations. Those recommendations would need to look at creating a “Natural Psychedelic Permit” for regulated access to psilocybin, DMT and mescaline that is not derived from natural peyote.
Recommendations for psychedelics regulations should also related to “growing natural psychedelic substances in accordance with agricultural safety standards” and “testing and packaging requirements for products containing natural psychedelic substances with clear and accurate labeling of potency.”
One of the more unique features of the proposed law is the requirement for the task force to make recommendations “for the sale and taxation of natural psychedelic substances.”
To that end, members would need to consider “restricting the sales of natural psychedelic substances to Natural Psychedelic Permit holders,” “systems for the sale and reasonable taxation of natural psychedelic substances to cover the cost of a Maryland Natural Psychedelic Substance Access Program,” “systems to support statewide online sales of natural psychedelic substances with home delivery” and “options for retail stores that sell natural psychedelic substances in communities in the State and opt to participate in the online sale and home delivery of the substances.”
Further, the panel would need to investigate criminal justice reforms related to psychedelics, such as decriminalizing non-violent activities involving entheogenic substances, expunging prior psychedelics-related criminal records and releasing people currently incarcerated over psychedelics.
If enacted, the bill would take effect on July 1, 2024 and sunset on June 30, 2026.
Maryland lawmakers have already shown a willingness to embrace psychedelics policy reform, with the legislature passing a bill in 2022 to create a state fund to provide “cost-free” access to substances like psilocybin, MDMA and ketamine for military veterans suffering from post-traumatic stress disorder (PTSD) and traumatic brain injury. The former Republican governor allowed that legislation to be enacted into law without his signature.
—
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Lawmakers in multiple states are exploring psychedelics reform issues during the 2024 legislative session.
For example, a Maine House committee is considering a bill to legalize psilocybin, allowing adults to access the psychedelic at licensed facilities while broadly ending the criminalization of personal use and possession of psilocybin.
On Tuesday, the governor of Massachusetts also promoted the testimony of activists who spoke in favor of her veterans-focused bill that would, in part, create a psychedelics work group to study the therapeutic potential of substances such as psilocybin.
As Nevada advocates continue the push for psychedelics reform, a joint legislative committee held a hearing last week with expert and public testimony on the therapeutic potential of substances like psilocybin. Law enforcement representatives also shared their concerns around legalization—but there was notable acknowledgement that some reforms should be enacted, including possible rescheduling.
A New York lawmaker recently introduced a bill that would create a pilot program to provide psilocybin therapy to 10,000 people, focusing on military veterans and first responders, while the legislature also considers broader psychedelics reform.
New Hampshire Lawmakers Clash Over Competing Marijuana Legalization Proposals, With Revisions Planned In The Week Ahead
Photo elements courtesy of carlosemmaskype and Apollo.
Fetterman Opposes Schumer’s Zyn Nicotine Pouch Crackdown For Same ‘Freedom’ Reasons He Backs Marijuana Legalization
As Irish Lawmakers Prepare To Debate Marijuana Bill, Prime Minister Pledges To Examine Drug Decriminalization As Recommended By Citizen Commission
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. His work has also appeared in High Times, VICE and attn.
Vermont Senate Panel Previews Amendment Narrowing House-Passed Safe Drug Consumption Site Bill To Single Facility
Justice Department Is Investigating Marijuana-Related Businesses Over COVID Relief Loans, Industry Sources Say
New Hampshire Governor Indicates He Won’t Sign House-Passed Marijuana Legalization Bill Unless Senate Makes Changes
Amended Nebraska Bill Reduces Proposed Hemp And CBD Tax Rate From 100% Down To 25%
These Marijuana Companies Are Funding Florida’s Legalization Ballot Campaign, New Records Show
FDA head tells DEA to not delay cannabis rescheduling (Newsletter: April 12, 2024)
All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell